RT Journal Article
SR Electronic
T1 A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders
JF Journal of Medical Genetics
JO J Med Genet
FD BMJ Publishing Group Ltd
SP 660
OP 668
DO 10.1136/jmedgenet-2012-101203
VO 49
IS 10
A1 Zufferey, Flore
A1 Sherr, Elliott H
A1 Beckmann, Noam D
A1 Hanson, Ellen
A1 Maillard, Anne M
A1 Hippolyte, Loyse
A1 Macé, Aurélien
A1 Ferrari, Carina
A1 Kutalik, Zoltán
A1 Andrieux, Joris
A1 Aylward, Elizabeth
A1 Barker, Mandy
A1 Bernier, Raphael
A1 Bouquillon, Sonia
A1 Conus, Philippe
A1 Delobel, Bruno
A1 Faucett, W Andrew
A1 Goin-Kochel, Robin P
A1 Grant, Ellen
A1 Harewood, Louise
A1 Hunter, Jill V
A1 Lebon, Sébastien
A1 Ledbetter, David H
A1 Martin, Christa Lese
A1 Männik, Katrin
A1 Martinet, Danielle
A1 Mukherjee, Pratik
A1 Ramocki, Melissa B
A1 Spence, Sarah J
A1 Steinman, Kyle J
A1 Tjernagel, Jennifer
A1 Spiro, John E
A1 Reymond, Alexandre
A1 Beckmann, Jacques S
A1 Chung, Wendy K
A1 Jacquemont, Sébastien
A1 on behalf of the Simons VIP Consortium
A1 on behalf of the 16p11.2 European Consortium
YR 2012
UL http://jmg.bmj.com/content/49/10/660.abstract
AB Background The recurrent ∼600 kb 16p11.2 BP4-BP5 deletion is among the most frequent known genetic aetiologies of autism spectrum disorder (ASD) and related neurodevelopmental disorders. Objective To define the medical, neuropsychological, and behavioural phenotypes in carriers of this deletion. Methods We collected clinical data on 285 deletion carriers and performed detailed evaluations on 72 carriers and 68 intrafamilial non-carrier controls. Results When compared to intrafamilial controls, full scale intelligence quotient (FSIQ) is two standard deviations lower in carriers, and there is no difference between carriers referred for neurodevelopmental disorders and carriers identified through cascade family testing. Verbal IQ (mean 74) is lower than non-verbal IQ (mean 83) and a majority of carriers require speech therapy. Over 80% of individuals exhibit psychiatric disorders including ASD, which is present in 15% of the paediatric carriers. Increase in head circumference (HC) during infancy is similar to the HC and brain growth patterns observed in idiopathic ASD. Obesity, a major comorbidity present in 50% of the carriers by the age of 7 years, does not correlate with FSIQ or any behavioural trait. Seizures are present in 24% of carriers and occur independently of other symptoms. Malformations are infrequently found, confirming only a few of the previously reported associations. Conclusions The 16p11.2 deletion impacts in a quantitative and independent manner FSIQ, behaviour and body mass index, possibly through direct influences on neural circuitry. Although non-specific, these features are clinically significant and reproducible. Lastly, this study demonstrates the necessity of studying large patient cohorts ascertained through multiple methods to characterise the clinical consequences of rare variants involved in common diseases.